Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hi, everybody. Thank you for joining the Emergent BioSolutions fireside chat. This is Albert Hwang from Morgan Stanley speaking. And again, thank you for joining. I have with me Rich Lindahl, the CFO of Emergent; and Bob Burrows, the Head of Investor Relations at Emergent. I will be -- there is no corporate presentation, but you can find it on their website. I will start with a few questions, but if you do have any questions, please feel free to ask them.
So maybe I can start. Rich, if you can give maybe a little bit about your background and then the current state of Emergent. The stock has actually done very well over the past few months. So I'd be curious to hear what you think that's attributed to.
Sure. Thank you very much, Albert, and good afternoon, everyone. Appreciate you taking the time to participate in our fireside chat today. So my name is Rich Lindahl. I'm the CFO of Emergent. I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |